Two Sigma Advisers LP decreased its holdings in shares of Bain Capital Specialty Finance, Inc. (NYSE:BCSF - Free Report) by 14.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 717,200 shares of the company's stock after selling 119,600 shares during the quarter. Two Sigma Advisers LP owned about 1.11% of Bain Capital Specialty Finance worth $11,906,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Quarry LP lifted its holdings in shares of Bain Capital Specialty Finance by 74.2% during the 2nd quarter. Quarry LP now owns 2,976 shares of the company's stock valued at $49,000 after acquiring an additional 1,268 shares in the last quarter. Quantbot Technologies LP acquired a new position in Bain Capital Specialty Finance in the 3rd quarter worth $136,000. BOKF NA acquired a new position in Bain Capital Specialty Finance in the 2nd quarter worth $159,000. Farther Finance Advisors LLC acquired a new position in Bain Capital Specialty Finance in the 3rd quarter worth $182,000. Finally, Centiva Capital LP acquired a new position in Bain Capital Specialty Finance in the 3rd quarter worth $199,000.
Analyst Ratings Changes
Separately, Keefe, Bruyette & Woods reiterated a "market perform" rating and issued a $17.00 price objective on shares of Bain Capital Specialty Finance in a report on Wednesday, August 21st.
Check Out Our Latest Stock Report on Bain Capital Specialty Finance
Bain Capital Specialty Finance Stock Performance
BCSF stock remained flat at $17.20 during trading on Tuesday. 144,943 shares of the company's stock were exchanged, compared to its average volume of 230,649. Bain Capital Specialty Finance, Inc. has a 52-week low of $14.75 and a 52-week high of $17.27. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.41 and a quick ratio of 1.41. The firm has a market capitalization of $1.11 billion, a P/E ratio of 8.61 and a beta of 1.12. The company has a fifty day moving average of $16.79 and a two-hundred day moving average of $16.65.
Bain Capital Specialty Finance (NYSE:BCSF - Get Free Report) last issued its earnings results on Tuesday, November 5th. The company reported $0.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.50 by $0.03. The business had revenue of $72.54 million for the quarter. Bain Capital Specialty Finance had a net margin of 43.62% and a return on equity of 11.90%. During the same quarter last year, the company posted $0.55 EPS. Sell-side analysts predict that Bain Capital Specialty Finance, Inc. will post 2.06 EPS for the current year.
Bain Capital Specialty Finance Profile
(
Free Report)
Bain Capital Specialty Finance, Inc is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt.
Further Reading
Before you consider Bain Capital Specialty Finance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bain Capital Specialty Finance wasn't on the list.
While Bain Capital Specialty Finance currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.